FOR IMMEDIATE RELEASE

Easysulin: Redefining Insulin Injection for Children

Easysulin is a specially designed insulin injection pen that aims to solve the health issues arising from repetitive insulin injections at the same site. With a focus on children with diabetes, Easysulin introduces innovative features to ensure precise and safe insulin administration.

The triangular pen body divides the injection angles into morning, noon, and evening, allowing for intuitive positioning based on the time of injection. By utilizing a tape measure, Easysulin ensures a stable distance interval for injections, effectively preventing adipose tissue thickening and other complications associated with repetitive site injections.

Designed to accommodate standard insulin cartridges, Easysulin offers a user-friendly interface, allowing for easy dose adjustment and precise injection positioning. The product development and design took place in Taiwan, with a rigorous testing phase concluding in January 2023.

Our design team conducted extensive research, consulting with healthcare professionals and patients to understand the challenges associated with insulin administration. The insights gathered from individuals with diabetes and medical experts were instrumental in shaping the unique features of Easysulin, ensuring it meets the specific needs of its users.

Recognizing the critical importance of addressing the challenges faced by young patients, Easysulin is a testament to our commitment to creating impactful and innovative solutions in the healthcare industry.

Lin Zhong-Wei, the lead designer of Easysulin, is a renowned figure in sustainable product and brand design. With a strong academic background and a track record of prestigious design awards, Lin Zhong-Wei's expertise and dedication have been pivotal in bringing Easysulin to fruition.

-END-